Entries by admin

Fennec Pharmaceuticals Announces $12.5 Million Debt Financing With Bridge Bank

RESEARCH TRIANGLE PARK, N.C., Feb. 04, 2019 — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate (STS) to be administered by infusion) for the prevention of ototoxicity induced by cisplatin chemotherapy in pediatric patients with solid tumors, announced a $12.5 million […]

Adherex Appoints Two Independent Directors

RESEARCH TRIANGLE PARK, NORTH CAROLINA — (Marketwire) – April 28, 2014 – Adherex Technologies, Inc. (TSX:AHX, OTC: ADHXF) today announced the appointment of Dr. Khalid Islam and Adrian Haigh to the Company’s Board of Directors, effective immediately.  With these additions, the Adherex Board is now comprised of five directors, four of whom are independent. “We welcome […]

Adherex Announces Two Sodium Thiosulfate Presentations for Prevention of Ototoxicity in Children at Asco Meeting

– COG STUDY ACCL0431 oral presentation for hearing protection in rare childhood cancers – SIOPEL 6 poster presentation for hearing protection in standard risk hepatoblastoma RESEARCH TRIANGLE PARK, NORTH CAROLINA–(Marketwire) – April 22, 2014) – Adherex Technologies, Inc. (TSX:AHX, OTC: ADHXF) today announced that both of the Phase III studies being conducted on Sodium Thiosulfate (STS) […]